Dr Lal Path Labs Ltd (LALPATHLAB) is listed on the NSE in the Healthcare Service Provider sector, Healthcare Services industry. Market capitalisation: 29657.24 Cr. Figures below are as reported and are shown with their source and date.
Dr. Lal PathLabs Ltd. engages in the business of running laboratories for carrying out pathological investigations. The company is headquartered in Gurgaon, Haryana and currently employs 4,048 full-time employees. The company went IPO on 2015-12-23. The firm is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Company’s subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
Source: finedge · as of 2026-09-29
Last close (₹): 1,843.7
Source: quantro_screener_metrics_job · as of 2026-10-22
Source: quantro_screener_metrics_job · as of 2026-10-23
| Year ended | Revenue (₹ Cr) | PAT (₹ Cr) | EPS (₹) |
|---|---|---|---|
| Mar 2026 | 2,762.9 | 504.8 | 30.13 |
| Mar 2025 | 2,461.4 | 487.1 | 29.14 |
| Mar 2024 | 2,226.6 | 357.7 | 21.42 |
| Mar 2023 | 2,016.9 | 238.9 | 14.33 |
| Mar 2022 | 2,087.4 | 344.8 | 20.69 |
Source: finedge · as of 2026-07-21
Source: finedge · as of 2026-03-31
Source: quantro_company_profiles · as of 2026-10-23
Figures computed 2026-10-23.